University Hospitals of North Midlands NHS Trust-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2020

  1. Capivasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer: The PAKT trial

    Journal of Clinical Oncology